Danica Pension Livsforsikringsaktieselskab bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 28,782 shares of the medical equipment provider’s stock, valued at approximately $13,268,000.
Other large investors have also modified their holdings of the company. ABN Amro Investment Solutions grew its stake in Intuitive Surgical by 20.2% during the 1st quarter. ABN Amro Investment Solutions now owns 30,250 shares of the medical equipment provider’s stock valued at $13,945,000 after acquiring an additional 5,094 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in Intuitive Surgical by 3.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 166,908 shares of the medical equipment provider’s stock valued at $76,943,000 after acquiring an additional 6,231 shares during the last quarter. Oslo Pensjonsforsikring AS purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $300,000. Andra AP fonden boosted its holdings in shares of Intuitive Surgical by 139.7% during the 1st quarter. Andra AP fonden now owns 50,050 shares of the medical equipment provider’s stock worth $23,073,000 after purchasing an additional 29,168 shares during the last quarter. Finally, Wilkerson Advisory Group LLC grew its position in shares of Intuitive Surgical by 1,117.1% in the first quarter. Wilkerson Advisory Group LLC now owns 426 shares of the medical equipment provider’s stock valued at $196,000 after purchasing an additional 391 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Analyst Upgrades and Downgrades
ISRG has been the subject of several recent research reports. Citigroup cut their price target on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a research note on Monday. Stifel Nicolaus dropped their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a report on Friday, July 17th. Barclays set a $651.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Thursday, April 23rd. Finally, Leerink Partners reduced their price target on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. Twenty-one research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $523.46.
Intuitive Surgical Stock Performance
Shares of Intuitive Surgical stock opened at $350.06 on Wednesday. The stock has a 50 day moving average of $412.30 and a 200 day moving average of $464.06. The firm has a market capitalization of $123.98 billion, a price-to-earnings ratio of 40.10, a PEG ratio of 2.72 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $342.10 and a fifty-two week high of $603.88.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 17.09% and a net margin of 28.45%.The company had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the previous year, the business earned $1.81 earnings per share. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 8.61 EPS for the current year.
Insider Activity at Intuitive Surgical
In related news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares in the company, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the transaction, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This trade represents a 49.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 7,169 shares of company stock worth $3,059,135. Company insiders own 0.60% of the company’s stock.
More Intuitive Surgical News
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Recent commentary highlights that Intuitive Surgical’s latest earnings were impressive, with the company continuing to post strong growth and beating expectations, which supports the long-term investment case. Article Title
- Positive Sentiment: Analysts and recent coverage argue the stock may be oversold, with Wall Street estimate revisions moving higher and some writers saying the pullback could create a buying opportunity for growth investors. Article Title
- Positive Sentiment: One valuation-focused piece says ISRG is being priced for slower growth than it is currently delivering, suggesting the stock could be undervalued if the company maintains its current pace. Article Title
- Neutral Sentiment: Multiple articles note that ISRG has become a heavily watched and widely discussed stock, reflecting heightened investor attention rather than a clear new business catalyst. Article Title
- Negative Sentiment: Despite the strong fundamentals, the stock has fallen sharply over the past several weeks, and several reports frame the decline as a correction driven by investor caution around valuation and recent price weakness. Article Title
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
See Also
- Five stocks we like better than Intuitive Surgical
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
